Wednesday, November 04, 2020 9:49:39 AM
Conference Venue: The 37th Annual J. Garber Galbraith, M.D., Scientific Session and Lecture
Title: Brain Tumor Immunology & Immunotherapy
Date/Time: Friday, Nov. 6 from 4:00 – 5:00 PM CST
Format: Guest Galbraith Lecturer
Presenting Author: Linda Liau, MD (in-person presentation)
Link: https://www.uab.edu/medicine/neurosurgery/education/continuing-medical-education/j-garber-galbraith-scientific-session-and-lecture
Socknostication: Press release after hours and before the weekend = 0% chance this happens, IMO
Conference Venue: SITC 2020
Title: Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
Date/Time: Either Wednesday, Nov. 11 from 5:15 – 5:45 PM EST or Friday, November 13 from 4:40 – 5:10 PM EST
Format: Poster Presentation – Poster available November 9th
Presenting Authors: Marnix L. Bosch, MBA, PhD; Linda Liau, MD; Keyoumars Ashkan, MD
Link: https://sitc.sitcancer.org/2020/abstracts/titles/
Socknostication: Press release after hours with TLD = 25% chance this happens, but something is afoot having these three involved in a mid-size conference, IMO
Conference Venue: SNO 2020
Title: LTBK-02 - Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
Date/Time: Friday, Nov 20 from 11:55 – 12:05 PM EST
Format: Late Breaking Clinical Trials
Presenting Author: Linda Liau, MD
Link: https://www.eventscribe.com/2020/SNO/agenda.asp?pfp=days&day=11/20/2020&theday=Friday&h=Friday%20%20November%2020&BCFO=P|G
Socknostication: Press release embargoed and aligned with presentation = 99.9% chance this happens, IMO. Main stage at a main conference and post-DL timing to release TLD seems accurate, IMO
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM